drugset / Trial / NCT00538330

Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer

NCT00538330

NaSingle-groupOpen-labelHealth-services research

Summary

Post operative adjuvant chemotherapy followed by adjuvant Tamoxifen vs nil for patients with operable breast cancer

Timeline

Start
2007-09
Primary completion
2020-09
Completion
2020-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Tamoxifen Small molecule

Indications